Possible risk reduction in esophageal cancer associated with MPO -463 A allele

Area of Science:

• Genetics and Cancer Epidemiology
• Molecular Biology
• Biochemistry

Background:

• Myeloperoxidase (MPO) produces hydroxy radicals, contributing to DNA damage and activating carcinogens.
• A specific MPO gene promoter polymorphism (-463 G/A) is linked to reduced MPO expression.
• Reduced MPO expression theoretically lowers susceptibility to smoking-related cancers like esophageal cancer.

Purpose of the Study:

• To investigate the association between the MPO -463 G/A polymorphism and esophageal cancer risk.
• To determine if the MPO -463 A allele confers protection against esophageal cancer, particularly in relation to smoking.

Main Methods:

• A case-control study was conducted with 91 esophageal cancer patients and 241 controls.
• MPO genotypes (-463 G/A) were analyzed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
• Statistical analysis included age, sex, smoking, and drinking status adjustments.

Main Results:

• The MPO -463A allele frequency was 8.2% in cases and 10.5% in controls.
• An adjusted odds ratio of 0.15 (P=0.022) indicated a significantly reduced risk for the GG/GA genotype in individuals aged 61 and older, especially smokers.
• No significant difference in risk was observed between prevalent and incident cases.

Conclusions:

• The MPO -463 A allele appears to reduce the risk of esophageal cancer.
• The protective effect may be more pronounced in older individuals with a history of smoking.
• Further research is warranted due to study limitations, including the use of prevalent cases and partial statistical significance.